Mitochondrial-Targeted and Near-Infrared Fluorescence Probe for Bioimaging and Evaluating Monoamine Oxidase A Activity in Hepatic Fibrosis.
Zheng-Min YangQing-Yuan MoJi-Man HeDong-Liang MoChenguo LiHua ChenShu-Lin ZhaoJiang-Ke QinPublished in: ACS sensors (2020)
Monoamine oxidase A (MAO-A) is a promising diagnostic marker for cancer, depression, Parkinson's disease, and liver disease. The fluorescence detection of MAO-A in living animals is of extreme importance for the early diagnosis of related diseases. However, the development of specific and mitochondrial-targeted and near-infrared (NIR) fluorescence MAO-A probes is still inadequate. Here, we designed and synthesized four NIR fluorescence probes containing a dihydroxanthene (DH) skeleton to detect MAO-A in complex biological systems. The specificity of our representative probe DHMP2 displays a 31-fold fluorescence turn-on in vitro, and it can effectively accumulate in the mitochondria and specifically detect the endogenous MAO-A concentrations in PC-3 and SH-SY5Y cell lines. Furthermore, the probe DHMP2 can be used to visualize the endogenous MAO-A activity in zebrafish and tumor-bearing mice. More importantly, it is the first time that the MAO-A activity of hepatic fibrosis tissues is detected through the probe DHMP2. The present study shows that the synthesized DHMP2 might serve as a potential tool for monitoring MAO-A activity in vivo and diagnosing related diseases.
Keyphrases
- living cells
- single molecule
- fluorescent probe
- quantum dots
- energy transfer
- fluorescence imaging
- oxidative stress
- small molecule
- photodynamic therapy
- gene expression
- cell death
- metabolic syndrome
- squamous cell carcinoma
- type diabetes
- young adults
- sensitive detection
- sleep quality
- squamous cell
- drug induced
- endoplasmic reticulum